Tianyi Xiang

Tianyi Xiang

Auto-generated profile, based on publicly available information

Tianyi Xiang

Department of Pharmaceutics, University of Minnesota, Minneapolis, MN 55455, United States

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2025 in Chemical Science
Verified
Journal Article
Open access
PDF file
ZZZhengzheng Zhou
Zhengzheng Zhou
VJVikram Chandrashekhar Joshi
Vikram Chandrashekhar Joshi
YGYiwang Guo
Yiwang Guo
TXTianyi Xiang
Tianyi Xiang
ZWZijian Wang
Zijian Wang
Changquan Calvin SunChangquan Calvin Sun
Changquan Calvin Sun
The elastic strain limit can reach up to 8.7% for form I celecoxib crystals grown via melt crystallization.

4 December 2024 in RSC Pharmaceutics
Verified
Journal Article
Open access
PDF file
TXTianyi Xiang
Tianyi Xiang
SSSichen Song
Sichen Song
Ronald SiegelRonald Siegel
Ronald Siegel
Changquan Calvin SunChangquan Calvin Sun
Changquan Calvin Sun
Determining the upper limits of drug loading in amorphous solid dispersion (ASD) with sufficient physical stability and release performance is critical for developing ASD-enabled tablets for poorly soluble drugs. Recent studies have highlighted the utility of the polymer overlap concentration, c*, in maintaining the physical stability of ASD formulations. The present work demonstrates the feasibility of effectively developing high drug loaded ASD tablets using the c* concept as a guide, with posaconazole as the model drug. By incorporating various material sparing formulation technologies, a record high 50% POS loaded tablet with adequate manufacturability and satisfactory dissolution performance was developed using 1.5 g of POS within 14 days. Physical stabilities of the ASD and tablet were maintained for at least 6 months under ambient conditions and 1 month at 40 °C.

19 November 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
QHQingyi He
Qingyi He
TXTianyi Xiang
Tianyi Xiang
SLShuyu Liu
Shuyu Liu
Changquan Calvin SunChangquan Calvin Sun
Changquan Calvin Sun

14 September 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SMSushmita Majumder
Sushmita Majumder
TXTianyi Xiang
Tianyi Xiang
CSChangquan Calvin Sun
Changquan Calvin Sun
NMNathan A. Mara
Nathan A. Mara

25 June 2024 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
XYXin Yao
Xin Yao
TXTianyi Xiang
Tianyi Xiang
SCShuang Chen
Shuang Chen
BABusayo D. Alagbe
Busayo D. Alagbe
GZGeoff G.Z. Zhang
Geoff G.Z. Zhang
ASAhmad Y. Sheikh
Ahmad Y. Sheikh

3 July 2026 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SSSoumyadeep Sen
Soumyadeep Sen
TGTianxiang Gao
Tianxiang Gao
TXTianyi Xiang
Tianyi Xiang
ZWZijian Wang
Zijian Wang
Changquan Calvin SunChangquan Calvin Sun
Changquan Calvin Sun
NMNathan A. Mara
Nathan A. Mara